background image for GxP Lifeline
GxP Lifeline

Showing items tagged as personalized medicine

  • 2021-bl-personalized-medicine-trends-2_132x132

    3 Ways to Rethink Regulatory Change in Personalized Medicine

    As the field of personalized medicine grows and evolves, and regulatory agencies such as the U.S. Food and Drug Administration (FDA) take steps to address regulatory oversight in the field, affected organizations should brace themselves for change and use it to their advantage. Here are three ways that companies in personalized medicine can approach regulatory obstacles as opportunities instead.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]